In Minnesota, biomedical companies PetVivo Holdings Inc. and Gel-Del Technologies Inc. have merged in a reverse triangular merger, meaning PetVivo created a subsidiary to buy out Gel-Del. PetVivo focuses on veterinary medical devices and partnered back in 2014 with Gel-Del to create a biomedical device similar to cartilage for dogs and horses who have osteoarthritis, which affects around 20 million dogs in Europe and the U.S. alone. Gel-Del focuses on thermoplastic biomaterials similar to human tissue and through their initial 2014 partnership, the two companies decided to merge. The merger is expected to close in April. PetVivo said it has potential human applications coming soon, so stay tuned.
Latest article
Dutch Queen promotes biobased building materials
In the Netherlands, Dutch Queen consort Máxima visited two Uden worksites promoting biobased building materials made from Netherlands fiber crops.
The March 26 visit...
ReefCircular launches crowdfunding campaign for shell bioconcrete
In Denmark, ReefCircular, a company developing a shell-based bioconcrete to help restore marine habitats, has launched a crowdfunding campaign on Kickstarter.
The company’s bioconcrete...
Aleph Farms raises $29 million for lab-grown steak
In Israel, cultivated meat producer Aleph Farms has raised $29 million to expand production at its Rehovot pilot plant and expand production into Europe...